Tsugitaka Natsume
- Biotechnology top 5%
- Marine Sponges and Natural Products 5
-
- Cancer-related Molecular Pathways 4
- Cancer Treatment and Pharmacology 3
- Pharmacology top 10%
- Microbial Natural Products and Biosynthesis 6
-
- Bioactive Natural Diterpenoids Research 3
- 14-3-3 protein interactions 3
- Cancer therapeutics and mechanisms 2
-
- Microtubule and mitosis dynamics 4
- Co-authors
- Motohiro KobayashiJunichi WatanabeTakashi MikamiKatsuhiko MiyasakaShigeru TsukagoshiSatoru TamaokiKoichi MiyazakiKazuto Nishio
- Cited by
- BiotechnologyOncologyPharmacology
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Tsugitaka Natsume
18 papers receiving 448 citations
Peers
Comparison fields: 5 of 54
- Biotechnology 120
- Oncology 198
- Pharmacology 116
- Toxicology 16
- Molecular Biology 276
Countries citing papers authored by Tsugitaka Natsume
This map shows the geographic impact of Tsugitaka Natsume's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tsugitaka Natsume with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tsugitaka Natsume more than expected).
Fields of papers citing papers by Tsugitaka Natsume
This network shows the impact of papers produced by Tsugitaka Natsume. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tsugitaka Natsume. The network helps show where Tsugitaka Natsume may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tsugitaka Natsume, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 16 | |
| 2 | 2007 | 9 | |
| 3 | Antiangiogenic activity of TZT-1027 (soblidotin) on chick chorioallantoic membrane and human umbilical vein endothelial cells. | 2007 | 8 |
| 4 | 2006 | 10 | |
| 5 | 2006 | 5 | |
| 6 | Combination effect of TZT-1027 (Soblidotin) with other anticancer drugs. | 2006 | 7 |
| 7 | 2003 | 46 | |
| 8 | 2002 | 11 | |
| 9 | 2001 | 14 | |
| 10 | 2001 | 10 | |
| 11 | 2000 | 45 | |
| 12 | 2000 | 42 | |
| 13 | 2000 | 60 | |
| 14 | 2000 | 3 | |
| 15 | 1999 | 7 | |
| 16 | 1997 | 78 | |
| 17 | Synoviocyte proliferation in joints of SCID mice induced by toxic shock syndrome toxin-1 stimulated T cells from patient with rheumatoid arthritis. | 1997 | 3 |
| 18 | 1995 | 88 |
About Tsugitaka Natsume
Tsugitaka Natsume is a scholar working on Biotechnology, Pharmacology and Oncology, having authored 18 papers that have together received 462 indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (6 papers), Marine Sponges and Natural Products (5 papers), Cancer-related Molecular Pathways (4 papers), Microtubule and mitosis dynamics (4 papers), Bioactive Natural Diterpenoids Research (3 papers), Cancer Treatment and Pharmacology (3 papers), 14-3-3 protein interactions (3 papers) and Cancer therapeutics and mechanisms (2 papers). The work is most often cited by research in Biotechnology (120 citations), Oncology (198 citations) and Pharmacology (116 citations). Tsugitaka Natsume has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Motohiro Kobayashi, Junichi Watanabe, Takashi Mikami, Katsuhiko Miyasaka, Shigeru Tsukagoshi, Satoru Tamaoki, Koichi Miyazaki, Kazuto Nishio, Masanori Murakoshi and Yasuhiro Koh. Their work appears in journals such as Cancer Science, Cancer, Chemical and Pharmaceutical Bulletin, Investigational New Drugs and The Pharmacogenomics Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.